Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.

Miyazaki, Kyle S; Kuang, Yu; Kwee, Sandi A

Miyazaki, Kyle S; Kuang, Yu; Kwee, Sandi A.

Afiliación

Miyazaki KS; Oncology Research Department and Hamamatsu/Queen's PET Imaging Center, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813 USA.
Kuang Y; Department of Medical Physics, School of Allied Health Sciences, University of Nevada Las Vegas, Las Vegas, NV USA.
Kwee SA; Oncology Research Department and Hamamatsu/Queen's PET Imaging Center, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813 USA ; University of Hawaii John A. Burns School of Medicine, Honolulu, HI USA.

Nucl Med Mol Imaging ; 49(2): 160-4, 2015 Jun.

Article en En | MEDLINE | ID: mdl-26082811

Palabras clave

Castrate-resistant prostate cancer; Fluorocholine; PET/CT; Radium-223 dichloride

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nucl Med Mol Imaging Año: 2015 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google